SYSTEMIC ADJUVANT THERAPY FOR NODE-NEGATIVE BREAST-CANCER - PROVEN OR PREMATURE

被引：22

作者：

PRITCHARD, KI

机构：

[1] SUNNYBROOK MED CTR, TORONTO M4N 3M5, ONTARIO, CANADA

[2] UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA

来源：

ANNALS OF INTERNAL MEDICINE | 1989年 / 111卷 / 01期

关键词：

D O I：

10.7326/0003-4819-111-1-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 4

页数：4

共 43 条

[1]

[Anonymous], 1988, NEW ENGL J MED, V319, P1681

[2]

[Anonymous], 1985, JAMA, V254, P3461

[3]

BAUM M, 1988, BRIT J CANCER, V57, P608

[4] ADJUVANT TAMOXIFEN IN PRIMARY BREAST-CANCER - INFLUENCE ON PLASMA-LIPIDS AND ANTITHROMBIN-III LEVELS [J].

BERTELLI, G ;

PRONZATO, P ;

AMOROSO, D ;

CUSIMANO, MP ;

CONTE, PF ;

MONTAGNA, G ;

BERTOLINI, S ;

ROSSO, R .

BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) :307-310

[5] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[6]

BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211

[7] TAMOXIFEN, SERUM-LIPOPROTEINS AND CARDIOVASCULAR RISK [J].

BRUNING, PF ;

BONFRER, JMG ;

HART, AAM ;

DEJONGBAKKER, M ;

LINDERS, D ;

VANLOON, J ;

NOOYEN, WJ .

BRITISH JOURNAL OF CANCER, 1988, 58 (04) :497-499

[8] IMPROVING THE QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A COMPARISON OF INTERMITTENT AND CONTINUOUS TREATMENT STRATEGIES [J].

COATES, A ;

GEBSKI, V ;

BISHOP, JF ;

JEAL, PN ;

WOODS, RL ;

SNYDER, R ;

TATTERSALL, MHN ;

BYRNE, M ;

HARVEY, V ;

GILL, G ;

SIMPSON, J ;

DRUMMOND, R ;

BROWNE, J ;

VANCOOTEN, R ;

FORBES, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) :1490-1495

[9] BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].

DEVITA, VT .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529

[10] A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J].

FISHER, B ;

REDMOND, C ;

DIMITROV, NV ;

BOWMAN, D ;

LEGAULTPOISSON, S ;

WICKERHAM, DL ;

WOLMARK, N ;

FISHER, ER ;

MARGOLESE, R ;

SUTHERLAND, C ;

GLASS, A ;

FOSTER, R ;

CAPLAN, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :473-478

← 1 2 3 4 5 →